Granite Point Capital Management’s Five Prime Therapeutics, Inc. FPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-80,000
| Closed | -$1.75M | – | 124 |
|
|
2017
Q4 | $1.75M | Buy |
80,000
+30,000
| +60% | +$658K | 0.17% | 32 |
|
|
2017
Q3 | $2.05M | Buy |
50,000
+20,000
| +67% | +$818K | 0.43% | 25 |
|
|
2017
Q2 | $903K | Hold |
30,000
| – | – | 0.22% | 57 |
|
|
2017
Q1 | $1.09M | Buy |
+30,000
| New | +$1.09M | 0.32% | 37 |
|
|
2015
Q4 | $1.91M | Buy |
+45,900
| New | +$1.91M | 0.29% | 23 |
|
|
2014
Q3 | – | Sell |
-40,000
| Closed | -$622K | – | 102 |
|
|
2014
Q2 | $622K | Sell |
40,000
-17,600
| -31% | -$274K | 0.43% | 54 |
|
|
2014
Q1 | $1.13M | Buy |
57,600
+37,600
| +188% | +$739K | 0.81% | 34 |
|
|
2013
Q4 | $336K | Buy |
+20,000
| New | +$336K | 0.06% | 87 |
|